Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Neurosci ; 27(21): 5823-34, 2007 May 23.
Artigo em Inglês | MEDLINE | ID: mdl-17522326

RESUMO

Recent evidence has implicated dynein and its regulatory factors dynactin and LIS1 in neuronal and non-neuronal cell migration. In the current study we sought to test whether effects on neuronal cell motility might reflect, in part, a role for these proteins in the growth cone. In chick sensory neurons subjected to acute laminin treatment dynein, dynactin, and LIS1 were mobilized strikingly and rapidly to the leading edge of the growth cone, where they were seen to be associated with microtubules converging into the laminin-induced axonal outgrowths. To interfere acutely with LIS1 and dynein function and to minimize secondary phenotypic effects, we injected antibodies to these proteins just before axon initiation. Antibody to both proteins produced an almost complete block of laminin-induced growth cone remodeling and the underlying reorganization of microtubules. Penetration of microtubules into the peripheral zone of differentiating axonal growth cones was decreased dramatically by antibody injection, as judged by live analysis of enhanced green fluorescent protein-tubulin and the microtubule tip-associated EB3 (end-binding protein 3). Dynein and LIS1 inhibition had no detectable effect on microtubule assembly but reduced the ability of microtubules to resist retrograde actin flow. In hippocampal neurons dynein, dynactin, and LIS1 were enriched in axonal growth cones at stage 3, and both growth cone organization and axon elongation were altered by LIS1 RNA interference. Together, our data indicate that dynein and LIS1 play a surprisingly prominent role in microtubule advance during growth cone remodeling associated with axonogenesis. These data may explain, in part, the role of these proteins in brain developmental disease and support an important role in diverse aspects of neuronal differentiation and nervous system development.


Assuntos
1-Alquil-2-acetilglicerofosfocolina Esterase/fisiologia , Axônios/fisiologia , Citoplasma/fisiologia , Dineínas/fisiologia , Cones de Crescimento/fisiologia , Proteínas Associadas aos Microtúbulos/fisiologia , Microtúbulos/fisiologia , 1-Alquil-2-acetilglicerofosfocolina Esterase/análise , Animais , Axônios/química , Embrião de Galinha , Citoplasma/química , Dineínas/análise , Gânglios Espinais/química , Gânglios Espinais/citologia , Gânglios Espinais/fisiologia , Cones de Crescimento/química , Proteínas Associadas aos Microtúbulos/análise , Microtúbulos/química , Ratos
2.
FEBS Lett ; 579(1): 251-8, 2005 Jan 03.
Artigo em Inglês | MEDLINE | ID: mdl-15620722

RESUMO

The abnormal hyperphosphorylation of tau protein is one of the hallmarks of Alzheimer disease and other tauopathies; as yet the exact role of various tau kinases in this pathology is not fully understood. Here, we show that injection of isoproterenol, an activator of cAMP-dependent kinase (PKA), into rat hippocampus bilaterally results in the activation of PKA, calcium/calmodulin-dependent kinase II and cyclin-dependent kinase-5, inhibition of protein phosphatase-2A, hyperphosphorylation of tau at several Alzheimer-like epitopes and a disturbance of spatial memory retention 48 h after the drug injection. These findings suggest the involvement of PKA and PKA-mediated signaling pathway in the Alzheimer-like tau hyperphosphorylation and memory impairment.


Assuntos
Proteínas Quinases Dependentes de AMP Cíclico/metabolismo , Hipocampo/enzimologia , Transtornos da Memória/enzimologia , Proteínas tau/metabolismo , Doença de Alzheimer/enzimologia , Animais , Proteínas Quinases Dependentes de Cálcio-Calmodulina/fisiologia , Proteínas Quinases Dependentes de AMP Cíclico/fisiologia , Quinase 5 Dependente de Ciclina , Quinases Ciclina-Dependentes/metabolismo , Quinases Ciclina-Dependentes/fisiologia , Hipocampo/efeitos dos fármacos , Injeções , Isoproterenol/administração & dosagem , Transtornos da Memória/induzido quimicamente , Fosforilação/efeitos dos fármacos , Ratos , Comportamento Espacial/efeitos dos fármacos , Proteínas tau/análise
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA